Article Details

Dragonfly Therapeutics Initiates Phase 2 Study of HER2 Targeting TriNKET® DF1001 in ...

Retrieved on: 2022-12-06 13:07:11

Tags for this article:

Click the tags to see associated articles and topics

Dragonfly Therapeutics Initiates Phase 2 Study of HER2 Targeting TriNKET® DF1001 in .... View article details on HISWAI: https://www.yahoo.com/entertainment/dragonfly-therapeutics-initiates-phase-2-130000668.html

Excerpt

Dragonfly Therapeutics, Inc. ("Dragonfly"), a biotechnology company developing novel therapies that harness the immune system to treat a broad ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up